Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Biotechnol ; 120(3): 251-61, 2005 Nov 21.
Article in English | MEDLINE | ID: mdl-16095743

ABSTRACT

RNA interference (RNAi) mediated by small interfering RNA (siRNA) has become a popular tool of examining the function of various genes. However, many studies have failed to identify any inhibitory effect of the siRNAs on the expression of the target gene, even though the siRNA being tested had been designed sequence-specifically. In order to determine if this failure is due to the incorrect choice of observation time rather than that of the target site of the gene of interest, this study examined the RNAi efficiency of a vector-driven siRNA targeting two different reporter proteins, EGFP and d2EGFP, whose targeted sequences were identical but the half-lives within the cells differed remarkably from each other (>24h versus 2h), during the time course after transfection. The EGFP expression levels in both cells were reduced in time-dependent manner but the reduction patterns were quite different from each other. The RNAi efficiency varied among the different observation time points and the time required for the maximum RNAi efficiency was proportional to the half-life of the target protein. Stable knocked down cell lines for EGFP expression were then established and the reduced EGFP expression levels in these cell lines were retained for a long period. These results suggest that the choice of an adequate observation time or the establishment of stable knocked down cells by antibiotic selection might be required for making an accurate evaluation of the RNAi effect on the target protein possessing a long half-life.


Subject(s)
Gene Silencing , Green Fluorescent Proteins/antagonists & inhibitors , RNA Interference , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacology , Animals , COS Cells , Cell Culture Techniques , Cell Line , Chlorocebus aethiops , Clone Cells , Flow Cytometry , Fluorescent Dyes , Gene Expression Regulation/drug effects , Gene Targeting , Genes, Reporter , Genetic Vectors , Green Fluorescent Proteins/chemistry , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Half-Life , Humans , Indoles , Kinetics , Luciferases/metabolism , Microscopy, Fluorescence , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Transfection
2.
Biochem Biophys Res Commun ; 326(4): 825-35, 2005 Jan 28.
Article in English | MEDLINE | ID: mdl-15607744

ABSTRACT

Due to their unique capacity for self-renewal in addition to their ability to differentiate into cells of all neuronal lineages, neuronal stem cells (NSCs) are promising candidates for cell replacement therapy in neuronal injury and neurodegenerative diseases. However, there are few studies on immune rejection, which is one of the main problems facing successful stem cell therapy. In order to determine if human NSC might be rejected after transplantation the MHC expression level was examined in the HB1.F3 cell line, which has previously been shown to exhibit NSC properties. The results showed low expression levels of the MHC class I molecules on the surfaces of these cells. A dramatic increase in the MHC class I expression level was observed when the cells were treated with IFN-gamma, TNF-alpha, and IL-1beta, alone or in combination. The maximum induction of MHC class I protein expression was observed at above 20ng/ml IFN-gamma 48h after the treatment. The apparent additive effects of TNF-alpha and IL-1beta in combination on the maximum induction of MHC class I expression exerted by IFN-gamma treatment were not observed. The MHC class I levels elevated by IFN-gamma were sustained for 72h after withdrawing the IFN-gamma. Therefore, this study introduced human cytomegalovirus (hCMV) US genes, which are known to be able to reduce the MHC class I expression level on the cell surface after infection, into HB1.F3 cells. The cells transfected with the hCMV US2, US3, US6 or US11 genes showed 20-50% reduction in the MHC class I expression level compared with the mock-transfected cells. These results suggest that NSC expresses high levels of the MHC class I proteins, and unless they are modified, might be rejected upon transplantation. In addition, the various viral stealth mechanisms can be exploited for stem cell transplantation.


Subject(s)
Cytomegalovirus/metabolism , Histocompatibility Antigens Class I/metabolism , Membrane Glycoproteins/metabolism , Neurons/metabolism , Stem Cells/metabolism , Transfection/methods , Viral Proteins/metabolism , Cell Line , Cytomegalovirus/genetics , Down-Regulation/drug effects , Down-Regulation/immunology , Feasibility Studies , Genetic Enhancement/methods , Histocompatibility Antigens Class I/immunology , Humans , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Neurons/cytology , Neurons/immunology , Stem Cells/cytology , Stem Cells/immunology , Viral Proteins/genetics , Viral Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...